Autoimmune or autoiflammatory? Bad to the bone

International Journal of Clinical Rheumatology

Volumn 10, Issue 1, 2015, Pages 5-7

  Adamopoulos, Iannis E ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SHRINERS HOSPITALS FOR CHILDREN NORTHERN CALIFORNIA   (United States)

Author keywords

autoantibodies; bone loss; inflammatory arthritis; osteoclasts; psoriatic arthritis; rheumatoid arthritis

Indexed keywords

ADAPTIVE IMMUNITY; ANKYLOSING SPONDYLITIS; AUTOIMMUNE DISEASE; AUTOINFLAMMATORY DISEASE; BONE EROSION; CELL ACTIVATION; IMMUNOCOMPETENT CELL; INNATE IMMUNITY; JUVENILE RHEUMATOID ARTHRITIS; NONHUMAN; OSTEOCLAST; OSTEOCLASTOGENESIS; PATHOGENESIS; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; REVIEW; RHEUMATOID ARTHRITIS;

EID: 84923208468     PISSN: 17584272     EISSN: 17584280     Source Type: Journal    
DOI: 10.2217/ijr.15.1     Document Type: Review

References (15)

1. Silverman GJ, Carson DA. Roles of B cells in rheumatoid arthritis. Arthritis Res. Ther. 5(Suppl. 4), S1-S6 (2003).
2. Kouskoff V, Korganow AS, Duchatelle V, Degott C, Benoist C, Mathis D. Organ-specific disease provoked by systemic autoimmunity. Cell 87(5), 811-822 (1996).
3. Gillespie MT. Impact of cytokines and T lymphocytes upon osteoclast differentiation and function. Arthritis Res. Ther. 9(2), 103 (2007).
4. Simonet WS, Lacey DL, Dunstan CR et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89(2), 309-319 (1997).
5. Adamopoulos IE, Tessmer M, Chao CC et al. IL-23 is critical for induction of arthritis, osteoclast formation, and maintenance of bone mass. J. Immunol. 187(2), 951-959 (2011).
6. Van Den Berg WB. Lessons from animal models of arthritis over the past decade. Arthritis Res. Ther. 11(5), 250 (2009).
7. Mcinnes IB, Schett G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 7(6), 429-442 (2007).
8. Adamopoulos IE, Suzuki E, Chao CC et al. IL-17A gene transfer induces bone loss and epidermal hyperplasia associated with psoriatic arthritis. Ann. Rheum. Dis. doi:10.1136/annrheumdis-2013-204782 (2014) (Epub ahead of print).
9. Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature 496(7446), 445-455 (2013).
10. Shin HS, Sarin R, Dixit N et al. Crosstalk among IL-23 and DNAX Activating Protein of 12 kDa-Dependent Pathways Promotes Osteoclastogenesis. J. Immunol. 194(1), 316-324 (2015)
11. Dixit N, Wu DJ, Belgacem YH, Borodinsky LN, Gershwin M, Adamopoulos IE. Leukotriene B4 activates intracellular calcium and augments human osteoclastogenesis. Arthritis Res. Ther. 16(6), 496 (2014).
12. Chiu YG, Shao T, Feng C et al. CD16 (FcRgammaIII) as a potential marker of osteoclast precursors in psoriatic arthritis. Arthritis Res. Ther. 12(1), R14 (2010).
13. Liao KP, Kurreeman F, Li G et al. Associations of autoantibodies, autoimmune risk alleles, and clinical diagnoses from the electronic medical records in rheumatoid arthritis cases and non-rheumatoid arthritis controls. Arthritis Rheum. 65(3), 571-581 (2013).
14. Amara K, Steen J, Murray F et al. Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition. J. Exp. Med. 210(3), 445-455 (2013).
15. Harre U, Georgess D, Bang H et al. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J. Clin. Invest. 122(5), 1791-1802 (2012).